Our site uses cookies necessary for its proper functioning. To improve your experience, other cookies may be used: you can choose to disable them. This can be changed at any time via the Cookies link at the bottom of the page.

ACRONIM : Aquitaine’s Care and Research organisation for inflammatory and Immune-Mediated diseases

Lupus Treatment Rheumatoid arthritis Diabetes Immunity Multiple sclerosis Inflammation Pathogenesis Asthma Inflammatory bowel disease Psoriasis Vitiligo Environnement Diet Prevention Comorbidity Inflammageing Biobank


The main objective of the ACRONIM FHU is to improve future inflammatory diseases care by:

  • identifying at-risk subjects
  • identify potential environmental factors involved in induction of inflammatory diseases
  • studying early stages of inflammatory diseases
  • identifying biomarkers predictive of the transition from symptom-free to clinical stages of disease
  • developing preventive strategies for at-risk subjects
  • developing new therapeutic strategies for early stages of inflammatory diseases, assuming that this “window of opportunity” is the most appropriate to induce long-term remission
  • studying the factors underlying comorbidities and accelerated ageing associated with inflammatory diseases

To reach our goals, we decided to remove barriers between medical specialties, and between clinicians and researchers with different expertise, including immunologists, philosophers, chemists, cell biologists, bioinformaticians, and biostatisticians.